keyword
https://read.qxmd.com/read/37877448/recent-advances-in-bronchoscopic-lung-volume-reduction-for-severe-copd-patients
#21
JOURNAL ARTICLE
Rein Posthuma, Anouk W Vaes, Martijn A Spruit, Lowie E G W Vanfleteren
PURPOSE OF REVIEW: Bronchoscopic lung volume reduction (BLVR) is a novel and effective treatment for a specific phenotype of chronic obstructive pulmonary disease (COPD) characterized by advanced emphysema with static lung hyperinflation and severe breathlessness. This review aims to provide an overview of the recent advances made in BLVR. RECENT FINDINGS: For achieving optimal outcomes with BLVR, patient selection and target lobe identification is crucial. BLVR has recently also been established to improve pulmonary function, exercise capacity and quality of life in COPD patients falling outside the standard treatment criteria, including patients with moderate hyperinflation, chronic hypercapnic failure or with very low diffusion capacity...
December 1, 2023: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/37855445/evaluation-and-management-of-persistent-air-leak
#22
REVIEW
Garret Duron, Elliot Backer, David Feller-Kopman
INTRODUCTION: Persistent air leaks (PAL) represent a challenging clinical problem for which there is not a clear consensus to guide optimal management. PAL is associated with significant morbidity, mortality, and increased length of hospital stay. There are a variety of surgical and non-surgical management options available. AREAS COVERED: This narrative review describes the current evidence for PAL management including surgical approach, autologous blood patch pleurodesis, chemical pleurodesis, endobronchial valves, and one-way valves...
2023: Expert Review of Respiratory Medicine
https://read.qxmd.com/read/37846369/endobronchial-valve-treatment-in-chronic-obstructive-pulmonary-disease-a-qualitative-study-of-patients-expectations
#23
JOURNAL ARTICLE
Ingeborg Farver-Vestergaard, Camilla Askov Mousing, Anders Løkke, Kathrine Bock, Thomas Decker Christensen, Morten Bendixen, Elisabeth Bendstrup, Lotte Hasling Kodbøl Jørgensen, Karoline Litrup King
OBJECTIVES: Endobronchial valve (EBV) treatment is a treatment option for selected patients with severe chronic obstructive pulmonary disease (COPD) to reduce dyspnea and improve quality of life. However, the procedure is associated with risk of complications, and not all patients achieve the expected outcomes. The present study explores patients' expectations while waiting for EBV treatment. METHODS: Fifteen patients accepted for EBV treatment at Aarhus University Hospital in Denmark from October 2020 to June 2021 participated in a 30-min, semi-structured interview about (1) the experience of living with COPD and (2) expectations regarding EBV...
2023: SAGE Open Medicine
https://read.qxmd.com/read/37702527/safety-of-home-discharge-with-a-chest-tube-after-bronchoscopic-lung-volume-reduction-complicated-by-persistent-airleak
#24
JOURNAL ARTICLE
Amit Bobby Mahajan, Mahwish Bari, Nancy Collar, Shourjo Chakravorty, Duy K Duong, Kei Suzuki, Priya P Patel, Michael J Weyant, Douglas K Hogarth
BACKGROUND: The incidence of pneumothorax after bronchoscopic lung volume reduction (BLVR) using Zephyr (Pulmonx Corporation) endobronchial valves is ~26%. Many patients who develop a postprocedural pneumothorax require chest tube placement. If a persistent airleak is present, patients tolerating waterseal can be discharged home with a mini-atrium with a low risk of empyema. METHODS: Data were collected on patients from the Epic (Epic System Corporation) electronic medical record between July 2019 and November 2022...
September 13, 2023: Journal of Bronchology & Interventional Pulmonology
https://read.qxmd.com/read/37684196/-bronchoscopic-copd-treatments
#25
REVIEW
T Egenod, G Deslee, B Degano
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is associated with disabling respiratory symptoms including dyspnea, frequent exacerbations and chronic bronchitis. The currently available pharmacological and non-pharmacological therapies have limited efficacy, necessitating the development of interventional strategies, many of them endoscopic. STATE OF THE ART: Endoscopic lung volume reduction has markedly increased over recent years, principally as regards the endobronchial valves currently used in routine care...
September 6, 2023: Revue des Maladies Respiratoires
https://read.qxmd.com/read/37673413/endobronchial-lung-volume-reduction-with-valves-reduces-exacerbations-in-severe-emphysema-patients
#26
JOURNAL ARTICLE
Judith Maria Brock, Felix Böhmker, Paul Ulrich Schuster, Ralf Eberhardt, Daniela Gompelmann, Konstantina Kontogianni, Susanne Dittrich, Nicola Benjamin, Felix Herth
BACKGROUND AND OBJECTIVE: Exacerbations drive the progression of chronic obstructive pulmonary disease (COPD). Endoscopic lung volume reduction (ELVR) with valves is an established treatment option for patients with severe emphysema. Post-interventional exacerbations are observed in 8-17% of cases. Whether the exacerbation rate changes in the medium term after ELVR, is not known. METHODS: This is a single-center retrospective analysis of severe emphysema patients with endobronchial valve implantation...
November 2023: Respiratory Medicine
https://read.qxmd.com/read/37661143/bronchoscopic-lung-volume-reduction-highlighting-the-patient-selection-process
#27
REVIEW
Max J Martin, Megan M Dulohery Scrodin, Eric S Edell, Eric A Aguirre, Srinivasan Rajagopalan, Brian J Bartholmai, Tobias Peikert
Patients with advanced emphysema frequently experience severe dyspnea that is inadequately treated with medical therapy alone. Over the past 4 years, we have seen increased usage of bronchoscopic lung volume reduction (BLVR) with endobronchial valves. Success of the procedure is dependent on patient selection because it is not necessarily appropriate for all patients with severe emphysema. (Table 1) The purpose of this review is to highlight the selection process at a single institution. We also discuss the influence of this process on outcomes...
September 2023: Mayo Clinic Proceedings
https://read.qxmd.com/read/37650092/the-impact-of-emphysema-heterogeneity-on-treatment-response-after-endobronchial-valve-treatment
#28
JOURNAL ARTICLE
Sharyn A Roodenburg, Karin Klooster, Dirk-Jan Slebos, Jorine E Hartman
BACKGROUND: Lung volume reduction with endobronchial valves can significantly improve functional outcomes in patients with advanced emphysema. The extent and spatial distribution pattern of emphysema shows considerable heterogeneity, which might affect response to endobronchial valve treatment. Our aim was to study the effect of emphysema heterogeneity on change in clinical outcomes after endobronchial valve treatment. METHODS: Data were collected from our national registry of patients who received endobronchial valve treatment between 2016 and 2020...
July 2023: ERJ Open Research
https://read.qxmd.com/read/37644125/attention-u-net-for-automated-pulmonary-fissure-integrity-analysis-in-lung-computed-tomography-images
#29
JOURNAL ARTICLE
Zachary W Althof, Sarah E Gerard, Ali Eskandari, Mauricio S Galizia, Eric A Hoffman, Joseph M Reinhardt
Computed Tomography (CT) imaging is routinely used for imaging of the lungs. Deep learning can effectively automate complex and laborious tasks in medical imaging. In this work, a deep learning technique is utilized to assess lobar fissure completeness (also known as fissure integrity) from pulmonary CT images. The human lungs are divided into five separate lobes, divided by the lobar fissures. Fissure integrity assessment is important to endobronchial valve treatment screening. Fissure integrity is known to be a biomarker of collateral ventilation between lobes impacting the efficacy of valves designed to block airflow to diseased lung regions...
August 29, 2023: Scientific Reports
https://read.qxmd.com/read/37633740/hypoxemia-may-occur-after-endobronchial-valve-deployment-the-mechanism-is-speculative-at-present
#30
EDITORIAL
Javier H Campos
No abstract text is available yet for this article.
May 7, 2023: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/37619428/bronchoscopic-lung-volume-reduction-with-endobronchial-valves-improves-respiratory-muscle-function-in-patients-with-severe-emphysema
#31
JOURNAL ARTICLE
Aurélien Brindel, Romane Fumat, Marion Dupuis, Romain Barthes, Florent Favard, Yannick Simonneau, Matthieu Dusselier, Valentin Heluain, Gavin Plat, Thomas Egenod, Nicolas Guibert
No abstract text is available yet for this article.
May 25, 2023: Respiratory medicine and research
https://read.qxmd.com/read/37555456/one-way-endobronchial-valves-in-the-management-of-complex-persistent-air-leaks-in-a-soft-tissue-sarcoma-patient
#32
Alfonso Fiorelli, Lucia Cannella, Francesca Capasso, Antonio Pizzolorusso, Feranda Picozzi, Gaetana Messina, Giovanni Natale, Edoardo Mercadante, Salvatore Tafuto
Complex persistent air leak (PAL) is a clinical condition which is difficult to treat. Herein, we report the clinical case of an 18-year-old woman with lung and bone metastases due an ultrarare sarcoma: "round cell sarcoma non-Ewing". She developed persistent air leaks due to an alveolopleural fistula which developed following two cycles of chemotherapy with doxorubicin. Chest drainage with suction failed to resolve the air leaks, while surgical treatment was unfeasible due to the poor clinical condition of the patient...
September 2023: Thoracic Cancer
https://read.qxmd.com/read/37543787/lung-volume-reduction-for-emphysema-using-one-way-endobronchial-valves-an-australian-cohort
#33
JOURNAL ARTICLE
Calvin Sidhu, Nicholas Wilsmore, Narinder Shargill, Kanishka Rangamuwa
Emphysema can be associated with gas trapping and hyperinflation, which negatively impacts on quality of life, life expectancy, and functional capacity. Lung volume reduction (LVR) surgery can reduce gas trapping and improve mortality in select patients but carries a high risk of major complications. Bronchoscopic techniques for LVR using one-way endobronchial valves (EBV) have become an established efficacious alternative to surgery. A bi-center retrospective cohort study was conducted on patients with severe emphysema who underwent endoscopic lung volume reduction (ELVR) using Pulmonx Zephyr EBVs...
August 4, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/37465561/response-to-endobronchial-valve-treatment-it-s-all-about-the-target-lobe
#34
JOURNAL ARTICLE
Jorine E Hartman, Sharyn A Roodenburg, Marlies van Dijk, T David Koster, Karin Klooster, Dirk-Jan Slebos
BACKGROUND: Bronchoscopic lung volume reduction using endobronchial valves (EBV) has been shown to be beneficial for severe emphysema patients. The most important predictor of treatment response is absence of collateral ventilation between the treatment target and ipsilateral lobe. However, there are still a substantial number of nonresponders and it would be useful to improve the pre-treatment identification of responders. Presumably, predictors of response will be multifactorial, and therefore our aim was to explore whether we can identify response groups using a cluster analysis...
July 2023: ERJ Open Research
https://read.qxmd.com/read/37434719/novel-treatment-of-bronchopleural-fistula-in-a-lung-transplant-recipient-with-endobronchial-sealant-and-endobronchial-valve-placement-via-robotic-assisted-bronchoscopy
#35
Ishaq J Wadiwala, Sebastian Fernandez-Bussy, Pankaj Garg, Mostafa Ali, Neil G Feinglass, Mathew Thomas, Si M Pham
Bronchopleural fistulas (BPFs) are a dreaded complication following pulmonary surgery. Endobronchial valves (EVs), with endobronchial sealant (ES), instilled with robotic bronchoscopy (RB), allow occlusion of BPF, avoiding surgery. The patient was a 71-year-old woman with a history of chronic obstructive pulmonary disease and bronchiectasis who underwent bilateral lung transplantation and wedge resection of the right middle lobe and left lingula. A BPF was discovered on postoperative day (POD) 21. Conservative measures with chest tubes failed, and robotic-assisted bronchoscopy aided in reaching the bronchial segment and instilling ES, and EV was deployed with the conventional bronchoscope...
July 2023: Journal of Surgical Case Reports
https://read.qxmd.com/read/37421336/lobar-quantification-of-pulmonary-perfusion-prior-to-minimally-invasive-lung-reduction-improves-prediction-of-post-procedure-outcomes-a-pilot-study
#36
JOURNAL ARTICLE
Kritika Subramanian, Brett Muench, Eugene Shostak, Amanda Coffey, Lady Sawoszczyk, Fei Gao, Adam Leep, Ramya Rajaram, John Hornung, Elisabeth O'Dwyer
BACKGROUND: Endobronchial valve placement is a minimally invasive option for treatment of patients with severe emphysema, by reducing lung volumes in lobes with both poor ventilation and perfusion; ventilation is determined by emphysematous scores and perfusion by quantitative lung perfusion imaging. CT-based fissure identifying artificial intelligence algorithms have recently demonstrated enhanced quantification of the perfusion in a 5-lobar analysis. We hypothesized that this newly developed algorithm may offer greater utility in determining target treatment lobes by supplementing the radiographic risk stratification initiated by the conventional emphysematous scores alone...
July 8, 2023: Clinical Physiology and Functional Imaging
https://read.qxmd.com/read/37414480/bronchoscopic-lung-volume-reduction-a-clinical-review
#37
REVIEW
Shourjo Chakravorty, Mahwish Bari, Duy Kevin Duong, Priya P Patel, Amit K Mahajan
Bronchoscopic lung volume reduction (BLVR) for the treatment of emphysema was originally developed in the early 2000s as a minimally invasive alternative to lung volume reduction surgery. Endobronchial valves for BLVR are an advancing "guideline treatment" in the treatment of advanced emphysema. Placement of small, one-way valves into segmental or subsegmental airways can induce lobar atelectasis for portions of diseased lung. This results in the reduction of hyperinflation along with improvements in diaphragmatic curvature and excursion...
August 2023: Thoracic Surgery Clinics
https://read.qxmd.com/read/37409351/from-plugging-air-leaks-to-reducing-lung-volume-a-review-of-the-many-uses-of-endobronchial-valves
#38
REVIEW
Jorrit B A Welling, T David Koster, Dirk-Jan Slebos
INTRODUCTION: One-way endobronchial valve treatment improves lung function, exercise capacity, and quality of live in patients with severe emphysema and hyperinflation. Other areas of therapeutic application include treatment of persistent air leak (PAL), giant emphysematous bullae, native lung hyperinflation, hemoptysis, and tuberculosis. AREAS COVERED: In this review, we will assess the clinical evidence and safety of the different applications of one-way endobronchial valves (EBV)...
July 7, 2023: Expert Review of Medical Devices
https://read.qxmd.com/read/37346445/endobronchial-hydatid-cyst-causing-variable-intrathoracic-airflow-limitation-selectively-during-expiration-acting-as-a-ball-valve
#39
JOURNAL ARTICLE
Pavan Kumar Dammalapati, Sandeep Kumar Kar, Chaitali Sen Dasgupta
UNLABELLED: Lung hydatid cyst is a frequently encountered site of echinococcus infection after the liver. Rupture of endobronchial hydatid cyst may lead to hydatemesis or may spread to the normal lung or can cause anaphylactic reactions. Performing bronchoscopy in cases with bronchial hydatid is controversial. The thoracic hydatid cyst may destroy the native lung parenchyma or may cause mass effect on the surrounding structures. Ball valve obstruction of the bronchial hydatid cyst is not documented in the literature and here the authors present such a case as the recognition of the ball valve mechanism is important as it may cause tension pneumothorax...
July 2023: Indian Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/37231891/endobronchial-valve-treatment-does-not-cause-significant-nickel-deposition-in-lung-tissue
#40
Sharyn A Roodenburg, Simon D Pouwels, Karin Klooster, Daan J Touw, Dirk-Jan Slebos
Bronchoscopic lung volume reduction using endobronchial valves (EBVs) is a treatment option for patients with severe emphysema. These EBVs are made out of a nitinol mesh covered by a silicone layer. Nitinol is an alloy of nickel and titanium and is commonly used in implantable medical devices because of its biocompatibility and memory-shape properties. However, there are some concerns that nickel ions can be released from nitinol-containing devices which might cause adverse health effects, especially in patients with a known nickel hypersensitivity...
May 10, 2023: Respiration; International Review of Thoracic Diseases
keyword
keyword
9049
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.